F. S. Mair et al.
FULL PAPER
1d: 2,6-iPr2C6H3NHCMeCHCMeN-2,6-iPr2C6H3 (4.2 g, 0.01 30.46 [CH(CH3)2 and tBu C(CH3)3], 27.42, 27.64, 27.82, 27.88,
mol), nBuLi (6.3 mL of a 1.6 hexane solution, 0.01 mol) and 28.15 [CH(CH3)2], 35.05, 35.18, 35.29 [tBu C(CH3)3], 72.46 (α-CH,
MeC(Cl)=N-2,6-iPr2C6H3 (2.5 mL, 0.01 mol) were used. Pale- triimine tautomer), 106.41, 111.09 (alkenyl α-C, enamine-diimine
green crystals from methanol/dichloromethane (2.90 g, 47%); m.p.
tautomers), 118.30, 118.57, 119.52, 119.83, 120.61, 123.42, 123.53,
123.89, 123.95, 124.15, 124.19, 124.37, 124.43, 124.55, 124.62,
124.87, 125.18, 125.43, 125.55, 125.71, 125.79, 125.81, 125.86,
125.89, 126.15, 126.21, 126.23, 126.32, 126.50, 126.52, 126.56,
166–168 °C. 1H NMR (500 MHz, CDCl3) triketimine tautomer
3
(50%, reported integrals are normalised): δ = 1.02 [d, JHH
=
3
6.7 Hz, 18 H, CH(CH3)2], 1.14 [d, JHH = 6.8 Hz, 18 H, CH-
(CH3)2], 1.89 (s, 9 H, CH3CN), 2.95 [sept, overlapped with unique 126.63 (aromatic CH), 138.06, 138.45, 139.64, 140.17, 141.21,
3
imine arm of enamine-diimine, JHH = 6.8 Hz, 6 H, CH(CH3)2], 141.81, 141.87, 142.19, 142.35, 142.51, 142.74, 143.17, 143.83,
4.74 (s, 1 H, α-CH) ppm; enamine-diimine tautomer (50%, re-
144.78, 146.56, 148.44, 148.80, 149.67, 149.94 (aromatic ipso-CN,
-CiPr and -CtBu), 156.88, 157.17, 157.50, 158.87, 158.97 (conju-
ported integrals are normalised): δ = 1.04 [d, 3JHH = 6.9 Hz, 12 H,
3
3
CH(CH3)2], 1.05 [d, JHH = 6.9 Hz, 6 H, CH(CH3)2], 1.06 [d, JHH gated C=N, enamine-diimine tautomers), 167.63, 168.63, 168.72,
= 6.9 Hz, 12 H, CH(CH3)2], 1.08 [d, 7.1 Hz, 6 H, CH(CH3)2], 1.86 169.88, 171.90 (isolated C=N, enamine-diimine tautomers/C=N,
(s, 6 H, CH3CN), 1.93 (s, 3 H, CH3CN), 2.95 [m, overlapped with triimine tautomer) ppm. C35H45N3 (507.76): calcd. C 82.79, H 8.93,
3
3
triketimine, JHH = 7.1 Hz, 2 H, CH(CH3)2], 3.08 [sept, JHH
=
N 8.28, found C 82.80, H 9.02, N 8.26. MS (ES+): m/z = 508.4
6.9 Hz, 4 H, CH(CH3)2], 13.5 (br. s, 1 H, NH) ppm; peaks due to
aromatic protons for both isomeric species (9 H): δ = 6.97–7.07
(non-first-order m) ppm. 13C{1H} NMR (125 MHz, CDCl3), peaks
due to both isomeric species (unless otherwise specified): δ = 19.03
[2 CH3C(N), enamine-diimine tautomer], 21.59 [CH3C(N), triimine
tautomer], 23.26, 23.34, 23.74, 23.83, 23.96, 24.36 [iPr CH(CH3)2],
25.27 [1 CH3C(N), enamine-diimine tautomer], 27.75, 27.84, 28.31
(iPr CH(CH3)2], 72.06 (α-CH, triimine tautomer), 108.68 (alkenyl
α-C, enamine-diimine tautomer), 122.96, 123.26, 123.34, 123.59,
123.79,123.35 (aromatic CH), 136.55, 136.87, 140.22, 142.47,
145.91, 146.12 (aromatic ipso-CN and -CiPr), 160.15 (conjugated
C=N, enamine-diimine tautomer), 169.01, 171.97 (isolated C=N,
enamine-diimine tautomer/C=N, triimine tautomer) ppm.
C43H61N3 (619.98): calcd. C 83.31, H 9.92, N 6.78; found C 82.87,
[MH]+. IR: ν = 1643, 1608, 1593, 1571 [ν(C=N)] 1537 [ν(C=C),
˜
aromatic] cm–1.
1f: 2-tBuC6H4NHCMeCHCMeN-2-tBuC6H4 (2.0 g, 0.0055 mol),
nBuLi (3.5 mL of
a 1.6 hexane solution, 0.0055 mol),
MeC(Cl)=N-2,6-iPr2C6H3 (1.3 mL, 0.0055 mol) and toluene
(40 mL) were used. Pale-yellow powder from methanol (0.60 g,
20%); m.p. 116–118 °C. 1H NMR (500 MHz, CDCl3), peaks due to
major (E) isomer of 2,6-iPr2C6H3NHCMeC[C(Me)=N-2-tBuC6H4]
CMeN-2-tBuC6H4 (57% abundant; reported integrals normalised):
3
δ = 1.298 [s, 9 H, C(CH3)3], 1.301 [s, 9 H, C(CH3)3], 1.00 [d, JHH
3
= 6.7 Hz, 6 H, CH(CH3)2], 1.14 [d, JHH = 6.9 Hz, 6 H, CH-
(CH3)2], 1.79, 1.94, 2.09 (3 s, 3ϫ3 H, H3CCN), 3.06 [2 sept over-
3
3
lapped, JHH = 6.7 Hz, 2ϫ1 H, CH(CH3)2], 6.47 (dd, JHH = 7.7,
4JHH = 1.3 Hz, 1 H, isolated imine aryl o-CH), 6.68 (dd, JHH
=
3
H 9.98, N 6.74. MS (ES+): m/z = 620.5 [MH]+. IR: ν = 1631, 1599,
˜
7.7, 4JHH = 1.3 Hz, enamine aryl o-CH), 6.92–7.10 (non-first-order
m, 7 H, aryl m- and p-CH), 7.29 (d overlapped with minor isomer
1585 [ν(C=N)], 1537 [ν(C=C), aromatic] cm–1.
3
4
peaks, 1 H, aryl m-CH), 7.32 (d, JHH = 7.9, JHH = 1.2 Hz, 1 H,
aryl m-CH), 13.30 (s), 13.89 (br. s, 1 H, NH) ppm; peaks due to
1e: 2-iPrC6H4NHCMeCHCMeN-2-iPrC6H4 (4.45 g, 0.013 mol),
nBuLi (8.2 mL of
a
1.6 hexane solution, 0.013 mol), (Z) isomer and triketimine form: both 19%, and minor (E)-2-
MeC(Cl)=N-2-tBuC6H4 (3.0 mL, 0.013 mol) and hexane (40 mL)
tBuC6H4NHCMeC[C(Me)=N-2,6-iPr2C6H3]CMeN-2-tBuC6H4 iso-
mer, 5%: δ = 0.85, 0.90, 0.94, 1.02, 1.04, 1.06, 1.09, 1.10 [8 d,
were used. Pale-yellow crystals from methanol/dichloromethane
(3.27 g, 50%); m.p. 130–133 °C. 1H NMR (500 MHz, CDCl3), 3 CH(CH3)2], 1.24, 1.28, 1.37, 1.43 [4 s, C(CH3)3], 1.75, 1.90, 1.93,
3
tautomers and 4 geometric isomers possible; (E) isomer of 2-
iPrC6H4NHCMeC[C(Me)=N-2-iPrC6H4]CMeN-2-tBuC6H4 tauto-
mer dominant (ca. 65%) peaks reported refer to this, unless other-
1.98, 2.03, 2.08, 2.42 (7 s, H3CN), 2.53 [sept, JHH = 6.5 Hz, 2 H,
triketimine CH(CH3)2], 2.88, 2.95 [2 sept, other isomers CH-
3
(CH3)2], 4.69 (s, 1 H, α-CH, triimine tautomer), 6.42 (dd, JHH
=
3
4
wise stated: δ = 1.04 [d, JHH = 6.9 Hz, 6 H, CH(CH3)2], 1.11 [d,
7.5 Hz, JHH = 1.2 Hz, 2 H, triketimine aryl o-CH), 6.54 (br. d, o-
aryl CH), 6.77, 7.26 (2 dd, mЈ-aryl CH), 13.25 [s, 1 H, (Z) isomer,
NH], 13.89 [br. s, minor (E) isomer, NH]. 13C{1H} NMR
(125 MHz, CDCl3), peaks due to all isomeric species (unless other-
wise specified): δ = 18.95, 19.03, 19.78, 20.28, 21.54, 21.95, 22.89,
23.00, 23.11, 23.73, 23.85, 23.99, 24.19, 24.41, 24.55, 25.05, 25.44,
30.96, 32.13 [iPr CH(CH3)2/CH3CN], 27.78, 28.26, 28.47
3JHH = 6.9 Hz, 6 H, CH(CH3)2] ppm; other isomers: δ = 0.90, 0.94,
(2 d, triketimine isomer, ca. 10%), 1.07 [2 overlapping d, (Z) isomer
of major tautomer, ca. 25%], 1.28 [s, 9 H, C(CH3)3] ppm; other
isomers: δ = 1.13, 1.29, 1.31, 1.38 [4 s, C(CH3)3], 1.92, 1.96, 2.00
(3 s, 3ϫ3 H, CH3CN) ppm; other isomers: δ = 1.63, 1.64, 1.74,
1.97, 1.98, 2.09, 2.44 (7 s, CH3CN), 3.02 [sept, 3JHH = 6.9 Hz, 1 H,
3
CH(CH3)2] 3.13 [sept, JHH = 6.9 Hz, 1 H, CH(CH3)2] ppm; other [CH(CH3)2], 29.58, 29.85, 30.44, 30.55, 31.27 [tBu C(CH3)3], 35.14,
isomers: δ = 2.67, 2.88, 2.97, 3.12, 3.26 [5 sept, CH(CH3)2], 4.60 (s,
35.19, 35.29, 36.08 [tBu C(CH3)3], 72.84 (α-CH, triimine tautomer),
105.97, 111.10 (alkenyl α-C, enamine-diimine tautomers), 119.42,
120.51, 121.26, 123.01, 123.21, 123.24, 123.34, 123.57, 123.61,
123.94, 124.16, 124.35, 124.81, 125.15, 125.42, 125.54, 125.70,
125.95, 126.26, 126.31, 126.33, 126.35, 126.45, 126.47, 126.53,
126.59, 126.61 (aromatic CH), 136.29, 136.83, 139.20, 139.43,
139.57, 140.23, 142.69, 142.77, 142.98, 143.29, 143.41, 143.48,
143.60, 144.09, 144.34, 144.99, 145.78, 146.93, 149.77, 149.85 (aro-
matic ipso-CN, -CiPr and -CtBu), 158.07, 158.43, 158.86, 159.61
(conjugated C=N, enamine-diimine tautomers), 164.98, 166.16,
167.91, 169.22 (isolated C=N, enamine-diimine tautomers/C=N,
3
4
α-CH, triimine tautomer), 6.53 (dd, JHH = 7.4, JHH = 1.2 Hz, 1
H, o-CH AriPr isolated imine), 6.73, (dd, 3JHH = 7.8, 4JHH = 1.2 Hz,
1 H, o-CH ArtBu enamine), 6.82–6.87 (non-first-order m, o-CH
AriPr enamine, 1 H + overlap from other isomers), 6.93–7.12 (non-
first-order m, m- and p-aryl CH, 6 H + overlap from other iso-
3
4
mers), 7.18 (dd, 1 H, mЈ-CH ArtBu), 7.24 (dd, JHH = 7.7, JHH
=
1.3 Hz, 1 H, mЈ-CH AriPr), 7.30 (dd, JHH = 7.8, JHH = 1.3 Hz, 1
H, mЈ-CH AriPr) ppm; other isomers: δ = 6.45, 6.47, 6.55, 6.60,
6.62, 6.68, 6.83 (dd, o-CH), 7.15, 7.21, 7.25, 7.29, 7.33 (dd, mЈ-aryl
CH) 13.38 (br. s, 1 H, NH) ppm; other isomers: δ = 13.20, 13.39,
3
4
13.65 (3 br. s) ppm. 13C{1H} NMR (125 Hz, CDCl3), peaks due to triimine tautomer) ppm. C39H53N3 (563.87): calcd. C 83.07, H 9.47,
all isomeric species (unless otherwise specified): δ = 18.42, 19.00
19.35 19.59, 19.76, 20.72, 21.12, 24.61, 25.08, 31.38 (CH3CN),
23.06, 23.11, 23.24, 23.28, 23.34, 23.42, 23.59, 29.63, 29.97, 30.36,
N 7.45; found C 83.20, H 9.40, N 7.45. MS (ES+): m/z = 564.4
[MH]+. IR: ν = 1638, 1602, 1586 [ν(C=N)] 1534 [ν(C=C), aromatic]
˜
cm–1.
1228
www.eurjic.org
© 2009 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim
Eur. J. Inorg. Chem. 2009, 1219–1233